Why do biotech firms have a strong financial incentive to target rich markets?
A.
Because more and more biotech research is being carried out in developing countries.
B.
Because government agencies and other private biotech companies can find and deliver biotech solutions for farmers in developing countries
C.
Because their products are often too costly for poor farmers in the developing world.
D.
Because it helps them rapidly recoup the high costs of product development